Efficacy and safety of advanced oral small molecules for inflammatory bowel disease: Systematic review and meta-analysis.
Virginia SolitanoSudheer K VuyyuruJohn K MacDonaldAlexa ZayadiClaire E ParkerNeeraj NarulaLaurent Peyrin-BirouletSilvio DaneseBrian G FeaganSiddharth SinghChristopher MaVipul JairathPublished in: Journal of Crohn's & colitis (2023)
JAKi and S1P receptor modulator therapies are effective in IBD for inducing clinical and endoscopic remission and, in some circumstances, histologic response.